Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
97.83
-0.40 (-0.41%)
At close: Sep 19, 2025, 4:00 PM EDT
97.70
-0.13 (-0.13%)
After-hours: Sep 19, 2025, 7:57 PM EDT
Boston Scientific Employees
Boston Scientific had 53,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.42% compared to the previous year.
Employees
53,000
Change (1Y)
5,000
Growth (1Y)
10.42%
Revenue / Employee
$348,943
Profits / Employee
$47,264
Market Cap
144.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 53,000 | 5,000 | 10.42% |
Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
Dec 31, 2019 | 36,000 | 4,000 | 12.50% |
Dec 31, 2018 | 32,000 | 3,000 | 10.34% |
Dec 31, 2017 | 29,000 | 2,000 | 7.41% |
Dec 31, 2016 | 27,000 | 2,000 | 8.00% |
Dec 31, 2015 | 25,000 | 1,000 | 4.17% |
Dec 31, 2014 | 24,000 | 1,000 | 4.35% |
Dec 31, 2013 | 23,000 | -1,000 | -4.17% |
Dec 31, 2012 | 24,000 | 0 | - |
Dec 31, 2011 | 24,000 | -1,000 | -4.00% |
Dec 31, 2010 | 25,000 | -1,000 | -3.85% |
Dec 31, 2009 | 26,000 | 1,200 | 4.84% |
Dec 31, 2008 | 24,800 | -2,700 | -9.82% |
Dec 31, 2007 | 27,500 | -1,100 | -3.85% |
Dec 31, 2006 | 28,600 | 8,800 | 44.44% |
Dec 31, 2005 | 19,800 | 2,300 | 13.14% |
Dec 31, 2004 | 17,500 | 2,500 | 16.67% |
Dec 31, 2003 | 15,000 | 1,100 | 7.91% |
Dec 31, 2002 | 13,900 | -500 | -3.47% |
Dec 31, 2001 | 14,400 | 680 | 4.96% |
Dec 31, 2000 | 13,720 | 1,105 | 8.76% |
Dec 31, 1999 | 12,615 | -1,385 | -9.89% |
Dec 31, 1998 | 14,000 | 3,000 | 27.27% |
Dec 31, 1997 | 11,000 | 1,420 | 14.82% |
Dec 31, 1996 | 9,580 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BSX News
- 1 day ago - Top 3 Health Care Stocks That May Explode In September - Benzinga
- 18 days ago - Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - PRNewsWire
- 26 days ago - 8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It. - Barrons
- 6 weeks ago - Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
- 6 weeks ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 6 weeks ago - Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Business Wire
- 7 weeks ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch
- 2 months ago - Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript - Seeking Alpha